- Home
- Venture Capital
- Life Sciences
- Portfolio
- Fovea Pharmaceuticals
Portfolio
Fovea Pharmaceuticals
- Country:
- France
- Activity:
- Ophthalmologic disorder drugs
- Entry:
- 2005
- Exit Mode:
- Sold to Sanofi-aventis - October 2009
- Website:
- www.fovea-pharma.com
Description
Fovea Pharmaceuticals was set up in 2005 to research and develop drugs for treating ophthalmologic disorders, such as age-related macular degeneration, retinitis pigmentosa and diabetic retinopathy. Fovea has developed a range of products in different stages of testing, from pre-clinical products to products about to undergo clinical testing. Over recent years Fovea has signed exclusive cooperation agreements with CombinatorRx Inc. and Novartis.